PALI

Palisade Bio, Inc. - Common Stock (PALI)

About Palisade Bio, Inc. - Common Stock (PALI)

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies for inflammatory bowel diseases. Its programs include PALI-2108 and LB1148. The company was founded on September 6, 2011 and is headquartered in Denver, CO.

Details

Daily high

$1.69

Daily low

$1.60

Price at open

$1.64

52 Week High

$2.86

52 Week Low

$0.58

Market cap

277.1M

Dividend yield

Volume

3.3M

Avg. volume

2.8M

P/E ratio

-2.97

Palisade Bio, Inc. - Common Stock News